P&G prevails in Utah
This article was originally published in The Rose Sheet
Executive Summary
Procter & Gamble indicates that it will continue to "take appropriate legal measures when competitors unfairly undermine the reputation of [its] brands or [the] company" in March 19 release announcing its legal victory over four Amway distributors in Salt Lake City federal district court. The jury awarded P&G $19.25 mil. in the suit, which revolved around the company's allegation that Amway employees perpetuated rumors suggesting ties between P&G and the Church of Satan. P&G previously had less success with its defamation charges, at least twice having been ordered to recompense Amway for its troubles following the suit's dismissal (1"The Rose Sheet" Jan. 10, 2000, In Brief)...
You may also be interested in...
P&G v. Amway
Houston district court orders Procter & Gamble to pay approximately $500,000 in Amway's legal fees and costs following dismissal of the company's suit charging Amway distributors with defamation; P&G said the employees repeated rumors that Procter & Gamble supports the Church of Satan. A similar case in Utah was dismissed in March, with P&G ordered to pay fines to Amway for bad faith litigation (1"The Rose Sheet" April 5, 1999, In Brief). According to Amway, "in 1995, a few distributors learned of the rumor" falsely linking P&G to Satanism "and innocently repeated it to one another because they believed it was true." P&G, Amway continues, "ignored that the rumor had been started 15 years earlier by others and that for years Amway had tried to help P&G squelch" the story. A separate suit filed by Amway in a Michigan court charging P&G with spreading damaging rumors is ongoing (2"The Rose Sheet" April 19, 1999, In Brief)
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.